Gasoline RBOB (RB February 2026)/ XFTTRBNYMETH / NYMEX ETH
RB5/15/2025 4:17:21 PM | Chg. -0.0425 | Bid9:42:54 AM | Ask9:42:04 AM | Open | High | Low | Previous Close |
---|---|---|---|---|---|---|---|
1.7648USD | -2.35% | 1.7512 | 1.7668 | 1.7700 | 1.7704 | 1.7645 | 1.8073 |
GlobeNewswire
5/15
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Bu...
GlobeNewswire
5/5
Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Inject...
GlobeNewswire
4/22
Zurab Tsereteli, Internationally Acclaimed Artist and Friend of Wolf Popper LLP, Dies at 91
GlobeNewswire
4/15
Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targe...
GlobeNewswire
4/1
REPEAT -- Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164...
GlobeNewswire
3/31
Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-...
GlobeNewswire
2/24
Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the...
GlobeNewswire
2/19
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
GlobeNewswire
2/18
Brunswick Exploration Announces 2025 Exploration Plans for Greenland and Stakes Additional Ground Ne...
GlobeNewswire
2/18
AMERICAN SALARS ACQUIRES 18,083 HECTARE BRAZIL HARDROCK LCT PEGMATITE PROPERTY WITH RECENT SAMPLING ...
GlobeNewswire
1/31
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
GlobeNewswire
1/30
Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Tr...
GlobeNewswire
8/22/2024
Regenx Tech to Present at the Clean Energy Metals Virtual Investor Conference August 29th